Subtype
Malignant Colorectal Neoplasm
CI-CAN-00005874Explore in graph →
1,565 active trials21 approved drugs382 evidence items
- NCIt
- C4978
- DOID
- 9256
- Other
- 1 more code
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00005874Explore in graph →
Clinical trials
7,296 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (722)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01163552 | Heated Chemotherapy for Cancers That Have Spread to the Chest Cavity | completed | Phase 2 | 5 | St. Luke's-Roosevelt Hospital CenterOTHER | 1 | Jun 13, 2014 | clinicaltrials |
| NCT00101348 | Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 66 | National Cancer Institute (NCI)NIH | 1 | Jun 11, 2014 |
| clinicaltrials |
| NCT01225744 | Erbitux Study of CPT11, Oxaliplatin, UFToral Targeted Therapy(eSCOUT) | completed | Phase 2 | 47 | The Christie NHS Foundation TrustOTHER | 1 | Jun 11, 2014 | clinicaltrials |
| NCT00675012 | NGR-hTNF Administered in Combination With a Standard Oxaliplatin Based Regimen in Patients With Metastatic Colorectal Cancer | completed | Phase 2 | 24 | AGC Biologics S.p.A.INDUSTRY | 1 | May 30, 2014 | clinicaltrials |
| NCT00006037 | Chemotherapy Plus IM-862 in Treating Patients With Metastatic Colorectal Cancer | terminated | Phase 2 | 18 | University of Southern CaliforniaOTHER | 1 | May 22, 2014 | clinicaltrials |
| NCT00159445 | Capecitabine and Gemcitabine in Patients With Metastatic Colorectal Cancer | completed | Phase 2 | 53 | University of Southern CaliforniaOTHER | 1 | May 22, 2014 | clinicaltrials |
| NCT00323011 | FOLFIRI + Bevacizumab With or Without Dalteparin in First Line Treatment of Advanced Colorectal Cancer | terminated | Phase 2 | 5 | University of Southern CaliforniaOTHER | 1 | May 21, 2014 | clinicaltrials |
| NCT01116687 | RO4929097 in Treating Patients With Metastatic Colorectal Cancer | completed | Phase 2 | 37 | National Cancer Institute (NCI)NIH | 1 | May 20, 2014 | clinicaltrials |
| NCT00504153 | Dasatinib in Treating Patients With Previously Treated Metastatic Colorectal Cancer | completed | Phase 2 | 19 | National Cancer Institute (NCI)NIH | 1 | May 19, 2014 | clinicaltrials |
| NCT01068132 | Prognostic Factors for Patients With Advanced Colorectal Cancer Treated With Cetuximab. | completed | Phase 2 | 54 | Regione LombardiaOTHER | 1 | May 12, 2014 | clinicaltrials |
| NCT02128425 | FOLFOXIRI Compared to FOLFOX in First Line Treatment of Metastatic Colorectal Cancer | unknown | Phase 2 | 162 | Sun Yat-sen UniversityOTHER | 1 | May 7, 2014 | clinicaltrials |
| NCT00814619 | Capecitabine and Radiation Therapy With or Without Panitumumab in Treating Patients With Advanced Rectal Cancer | completed | Phase 2 | 68 | Swiss Cancer InstituteOTHER | 2 | Apr 30, 2014 | clinicaltrials |
| NCT00625651 | Phase 1b/2 Study of AMG 655 With mFOLFOX6 and Bevacizumab for First-Line Metastatic Colorectal Cancer | completed | Phase 1 / Phase 2 | 202 | AmgenINDUSTRY | 1 | Apr 25, 2014 | clinicaltrials |
| NCT02117557 | Safety Study of Transumbilical Single Incision Versus Conventional Laparoscopic Surgery for Colorectal Cancer | unknown | Phase 2 | 198 | Guoxin LiOTHER | 1 | Apr 21, 2014 | clinicaltrials |
| NCT02118064 | Phase II Study to Evaluate G17DT in Combination With Irinotecan in Patients With Colorectal Carcinoma(CC6) | completed | Phase 2 | 161 | Cancer Advances Inc.INDUSTRY | 0 | Apr 21, 2014 | clinicaltrials |
| NCT00109226 | A Study to Evaluate Avastin in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancer | completed | Phase 2 | — | Genentech, Inc.INDUSTRY | 0 | Apr 8, 2014 | clinicaltrials |
| NCT00494221 | A Phase I/II Study of Cediranib (AZD2171) in Japanese Metastatic Colorectal Cancer Patients in Combination With FOLFOX | completed | Phase 1 / Phase 2 | 172 | AstraZenecaINDUSTRY | 1 | Mar 27, 2014 | clinicaltrials |
| NCT01320267 | Single Port Laparoscopic Colectomy(SILS) | withdrawn | Phase 1 / Phase 2 | 0 | University of British ColumbiaOTHER | 0 | Mar 17, 2014 | clinicaltrials |
| NCT00003786 | Irofulven in Treating Patients With Metastatic or Recurrent Colorectal Cancer | withdrawn | Phase 2 | 0 | University of ChicagoOTHER | 1 | Mar 7, 2014 | clinicaltrials |
| NCT00003950 | Irinotecan and Cyclosporine in Treating Patients With Metastatic, Advanced or Locally Recurrent Colorectal Cancer | completed | Phase 2 | 16 | University of ChicagoOTHER | 1 | Mar 7, 2014 | clinicaltrials |
| NCT01434147 | Preoperative Combined Induction Chemotherapy With Capecitabine, Oxaliplatin, Bevacizumab and Radiotherapy | completed | Phase 2 | 25 | Austrian Breast & Colorectal Cancer Study GroupNETWORK | 1 | Mar 7, 2014 | clinicaltrials |
| NCT01426490 | The Effects of Vitamin B-6 Status on Homocysteine, Oxidative Stress, One-carbon Metabolism and Methylation: Cross-section, Case-control, Intervention and Follow-up Studies in Colorectal Cancer | unknown | Phase 2 / Phase 3 | 300 | Taichung Veterans General HospitalOTHER | 1 | Feb 19, 2014 | clinicaltrials |
| NCT00630786 | Conatumumab/Panitumumab Combination Metastatic Colorectal Cancer Study | completed | Phase 1 / Phase 2 | 53 | AmgenINDUSTRY | 0 | Feb 6, 2014 | clinicaltrials |
| NCT00606398 | Combined Resection of Colorectal Metastases(CRC) | completed | Phase 2 | 56 | University Health Network, TorontoOTHER | 1 | Jan 27, 2014 | clinicaltrials |
| NCT00553683 | Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer | unknown | Phase 1 / Phase 2 | 50 | Rutgers, The State University of New JerseyOTHER | 1 | Jan 14, 2014 | clinicaltrials |
| NCT00795301 | A Study of Radiotherapy in Rectal Cancer Using Oxaliplatin, Capecitabine With or Without Cetuximab | unknown | Phase 2 | 74 | National University Hospital, SingaporeOTHER | 1 | Jan 14, 2014 | clinicaltrials |
| NCT00819754 | A Phase I/II Study of IXO With Bevacizumab in Patients With Metastatic Colorectal Cancer(IXO+A) | terminated | Phase 1 / Phase 2 | 23 | Ottawa Hospital Research InstituteOTHER | 1 | Jan 14, 2014 | clinicaltrials |
| NCT00967655 | Capecitabine, Panitumumab, and Radiation Therapy With or Without Irinotecan Hydrochloride in Treating Patients Undergoing Surgery for Localized Rectal Cancer | unknown | Phase 2 | 54 | Loma Linda Oncology Medical Group, Inc.OTHER | 1 | Jan 10, 2014 | clinicaltrials |
| NCT01067053 | Efficacy/Safety Study of Bevacizumab,Capecitabine,Oxaliplatin to Metastatic Colorectal Adenocarcinoma Elderly Patients.(BECOX) | unknown | Phase 2 | 69 | Grupo Espanol Multidisciplinario del Cancer DigestivoOTHER | 1 | Jan 9, 2014 | clinicaltrials |
| NCT00027833 | Vaccine Therapy and Chemotherapy With or Without Tetanus Toxoid Compared With Chemotherapy Alone in Treating Patients With Metastatic Colorectal Cancer | unknown | Phase 2 | — | Herbert Irving Comprehensive Cancer CenterOTHER | 2 | Jan 6, 2014 | clinicaltrials |
| NCT00297141 | Preoperative Combined Radiochemotherapy for Patients With Rectal Carcinoma | completed | Phase 2 | 60 | Austrian Breast & Colorectal Cancer Study GroupNETWORK | 1 | Dec 31, 2013 | clinicaltrials |
| NCT02022852 | Neoadjuvant Sequential Therapy in Locally Advanced Mid/Low Rectal Cancer | unknown | Phase 2 | 80 | Harbin Medical UniversityOTHER | 1 | Dec 30, 2013 | clinicaltrials |
| NCT00408551 | Chemotherapy and Internal Radiation in Treating Patients With Colorectal Cancer That Has Spread to the Liver | unknown | Phase 2 | 20 | Goshen Health SystemOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00975897 | Study of Tumor Tissue Testing in Selecting Treatment for Patients With Metastatic or Locally Advanced Colorectal Cancer | completed | Phase 2 / Phase 3 | 3,240 | Medical Research CouncilOTHER_GOV | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00031616 | NB1011 in Treating Patients With Metastatic or Recurrent Colorectal Cancer | unknown | Phase 1 / Phase 2 | — | NewBioticsINDUSTRY | 1 | Dec 18, 2013 | clinicaltrials |
| NCT00111761 | Evaluating Panitumumab (ABX-EGF) in Patients With Metastatic Colorectal Cancer | completed | Phase 2 | 43 | AmgenINDUSTRY | 0 | Dec 12, 2013 | clinicaltrials |
| NCT00852228 | Optimal Control of Liver Metastases From Colorectal Cancer With Cetuximab and Hepatic Artery Infusion of Chemotherapy(OPTILIV) | unknown | Phase 2 | 60 | Association pour la Recherche sur le Temps Biologique et la ChronothérapieOTHER | 4 | Dec 12, 2013 | clinicaltrials |
| NCT00005877 | Nitrocamptothecin in Treating Patients With Advanced or Recurrent Colorectal Cancer | unknown | Phase 2 | — | Astex Pharmaceuticals, Inc.INDUSTRY | 1 | Dec 4, 2013 | clinicaltrials |
| NCT01529164 | Efficacy and Safety Study of Recombinant Endostatin Combined With Chemotherapy to Treat Advanced Colorectal Cancer | unknown | Phase 2 | 51 | Chinese Academy of Medical SciencesOTHER | 1 | Nov 27, 2013 | clinicaltrials |
| NCT00215982 | Study of Capecitabine With Irinotecan and Oxaliplatin (Eloxatin) in Advanced Colorectal Cancer | completed | Phase 2 | 24 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 2 | Nov 25, 2013 | clinicaltrials |
| NCT00986518 | T Regulatory Lymphocytes (Treg) Depletion for Cancer Treatment Efficacy and Safety Study(STARTREK) | completed | Phase 1 / Phase 2 | 5 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Nov 25, 2013 | clinicaltrials |
| NCT01344902 | An Open Dose-finding Study of Oral Applied Hexaminolevulinate (HAL) Imaging in Patients With Suspicion or High Risk of Neoplasia in the Colon | terminated | Phase 1 / Phase 2 | 13 | PhotocureINDUSTRY | 1 | Oct 23, 2013 | clinicaltrials |
| NCT00262808 | GM-CSF and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Colon Cancer | completed | Phase 2 | 50 | University of RochesterOTHER | 1 | Oct 16, 2013 | clinicaltrials |
| NCT00909987 | Study of Neoadjuvant CT With Selective Radiotherapy in Patients With Intermediate-Risk Cancer Rectum | completed | Phase 2 | 46 | Grupo Espanol Multidisciplinario del Cancer DigestivoOTHER | 1 | Oct 11, 2013 | clinicaltrials |
| NCT00007826 | Monoclonal Antibody Therapy and/or Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer | unknown | Phase 1 / Phase 2 | — | OnyvaxINDUSTRY | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00625625 | Lymphatic Mapping, Sentinel Lymph Node Analysis, and Blood Tests in Detecting and Predicting Early Micrometastases in Patients With Colorectal Cancer | unknown | Phase 2 | 225 | Saint John's Cancer InstituteOTHER | 0 | Sep 17, 2013 | clinicaltrials |
| NCT01110785 | Simvastatin and Panitumumab in Treating Patients With Advanced or Metastatic Colorectal Cancer | unknown | Phase 2 | 46 | Leiden University Medical CenterOTHER | 1 | Sep 17, 2013 | clinicaltrials |
| NCT00475293 | Panitumumab in Combination With Irinotecan Chemotherapy as 2nd-line Therapy in Subjects With mCRC | completed | Phase 2 | 85 | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)OTHER | 1 | Sep 13, 2013 | clinicaltrials |
| NCT00022477 | BMS-247550 in Treating Patients With Recurrent or Metastatic Colorectal Cancer | completed | Phase 2 | 24 | University of ChicagoOTHER | 1 | Sep 5, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Jun 13, 2014source: clinicaltrials